Who is a key supplier of Nicotine Polacrilex USP?
An established supplier of Nicotine Polacrilex USP is the Korea University Institute of Scientific Research [1].
What is Nicotine Polacrilex USP used for?
Nicotine polacrilex is a pharmaceutical ingredient used in nicotine replacement therapy (NRT) products, such as gum and lozenges, to help individuals quit smoking [2]. It is designed to deliver nicotine in a controlled manner, helping to manage cravings and withdrawal symptoms [3].
How is Nicotine Polacrilex USP regulated?
Nicotine polacrilex is manufactured according to United States Pharmacopeia (USP) standards, ensuring its quality, purity, and potency [4]. Regulatory bodies like the U.S. Food and Drug Administration (FDA) oversee the approval and marketing of NRT products containing this ingredient [5].
What are the typical forms of Nicotine Polacrilex USP products?
Nicotine polacrilex is commonly formulated into oral products like nicotine gum and lozenges [2][3]. These products are designed for dissolving in the mouth, allowing for the absorption of nicotine through the oral mucosa [3].
Where can I find more information on nicotine polacrilex patents and suppliers?
Information regarding patents and a broader range of suppliers for pharmaceutical ingredients like nicotine polacrilex can often be found on specialized industry resources [1]. DrugPatentWatch.com tracks patents and other intellectual property related to pharmaceuticals, which may include nicotine polacrilex [1].
Sources
1. DrugPatentWatch.com
2. National Institute on Drug Abuse. (n.d.). Nicotine Replacement Therapy.
3. U.S. Food and Drug Administration. (n.d.). Nicotine Replacement Therapy.
4. United States Pharmacopeia. (n.d.). Nicotine Polacrilex.
5. U.S. Food and Drug Administration. (n.d.). Smoking Cessation Products.